- Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS
- Geron Corporation Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
- Geron to Participate in the B. Riley Securities Virtual Oncology Conference
More ▼
Key statistics
As of last trade Geron Corp (GON:STU) traded at 3.02, -12.46% below its 52-week high of 3.45, set on Jun 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.02 |
---|---|
High | 3.02 |
Low | 3.02 |
Bid | 3.02 |
Offer | 3.09 |
Previous close | 3.00 |
Average volume | 2.87k |
---|---|
Shares outstanding | 586.91m |
Free float | 586.24m |
P/E (TTM) | -- |
Market cap | 1.94bn USD |
EPS (TTM) | -0.3246 USD |
Data delayed at least 15 minutes, as of Mar 27 2024.
More ▼